Mona Alibolandi
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery 63
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 9
- Molecular Medicine top 2%
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 31
- Biosensors and Analytical Detection 20
- Graphene and Nanomaterials Applications 16
- Molecular Biology top 2%
- Advanced biosensing and bioanalysis techniques 77
- RNA Interference and Gene Delivery 59
- DNA and Nucleic Acid Chemistry 9
- Co-authors
- Khalil AbnousMohammad RamezaniSeyed Mohammad TaghdisiFarzin HadizadehMarzieh MohammadiFatemeh SadeghiNoor Mohammad DaneshElnaz Bagheri
- Journals
- SHILAP Revista de lepidopterología (6 papers)Analytical Biochemistry (2 papers)Scientific Reports (1 paper)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Mona Alibolandi
161 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 126
- Biomaterials 2.1k
- Pharmaceutical Science 385
- Molecular Medicine 290
- Biomedical Engineering 2.4k
- Molecular Biology 3.4k
Countries citing papers authored by Mona Alibolandi
This map shows the geographic impact of Mona Alibolandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Alibolandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Alibolandi more than expected).
Fields of papers citing papers by Mona Alibolandi
This network shows the impact of papers produced by Mona Alibolandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Alibolandi. The network helps show where Mona Alibolandi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mona Alibolandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 4 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 46 | |
| 17 | 2019 | 18 | |
| 18 | 2016 | 10 | |
| 19 | 2016 | 19 | |
| 20 | High level expression of human basic fibroblast growth factor in Escherichia coli: Evaluating the effect of the GC content and rare codons within the first 13 codons | 2010 | 8 |
About Mona Alibolandi
Mona Alibolandi is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering, having authored 165 papers that have together received 5.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (77 papers), Nanoparticle-Based Drug Delivery (63 papers), RNA Interference and Gene Delivery (59 papers), Nanoplatforms for cancer theranostics (31 papers), Biosensors and Analytical Detection (20 papers), Graphene and Nanomaterials Applications (16 papers), DNA and Nucleic Acid Chemistry (9 papers) and Advanced Drug Delivery Systems (9 papers). The work is most often cited by research in Biomaterials (2.1k citations), Pharmaceutical Science (385 citations) and Molecular Medicine (290 citations). Mona Alibolandi has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Khalil Abnous, Mohammad Ramezani, Seyed Mohammad Taghdisi, Farzin Hadizadeh, Marzieh Mohammadi, Fatemeh Sadeghi, Noor Mohammad Danesh, Elnaz Bagheri, Sara Amel Farzad and Sahar Taghavi. Their work appears in journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.